Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
Jerald Sadoff(University of Maryland, Baltimore), Macaya Douoguih(Johnson & Johnson (Netherlands)), Georgi Shukarev(University of Maryland, Baltimore), Hanneke Schuitemaker(Johnson & Johnson (Israel)), Gert C. Scheper(University of Maryland, Baltimore), Beatriz Grinsztejn(Fundação Oswaldo Cruz), Paul Goepfert(University of Maryland, Baltimore), Hein Fennema(University of Maryland, Baltimore), Kathleen M. Neuzil(Center for Global Development), Frank Struyf(Janssen (Belgium)), Dan H. Barouch(Beth Israel Deaconess Medical Center), Jeffrey J. Stoddard(University of Maryland, Baltimore), Karin Hardt(University of Maryland, Baltimore), An Vandebosch(University of Maryland, Baltimore), Lawrence Corey(Fred Hutch Cancer Center), Martin Ryser(University of Maryland, Baltimore), Kim Offergeld(University of Maryland, Baltimore), Javier Ruiz‐Guiñazú(University of Maryland, Baltimore), Merlin L. Robb(University of Maryland, Baltimore), Carla Truyers(University of Maryland, Baltimore), Mary Marovich(University of Maryland, Baltimore), Nancy Cauwenberghs(University of Maryland, Baltimore), Bart Spiessens(University of Maryland, Baltimore), Tamzin Tanner(University of Maryland, Baltimore), Vicky Cárdenas(University of Maryland, Baltimore), Kimberly L. Taylor(University of Maryland, Baltimore), Johan Van Hoof(University of Maryland, Baltimore), John J. Treanor(University of Maryland, Baltimore), Mathieu Le Gars(University of Maryland, Baltimore), Glenda Gray(South African Medical Research Council)
Cited by 2,597
Related Papers
Influenza
|Nature Reviews Disease Primers|2018|1.5k
Gender-based violence, relationship power, and risk of HIV infection in women attending antenatal clinics in South Africa
|The Lancet|2004|1.3k
Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection
|New England Journal of Medicine|1990|1.3k
Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion Protein
|New England Journal of Medicine|1996|1.3k